Market Closed -
Nyse
04:00:02 2024-05-23 pm EDT
|
5-day change
|
1st Jan Change
|
18.13
USD
|
-1.57%
|
|
+1.28%
|
+2.66%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,672
|
1,180
|
1,033
|
939.9
|
825.1
|
850.3
|
-
|
-
|
Enterprise Value (EV)
1 |
1,966
|
1,425
|
1,204
|
1,097
|
973.2
|
982.3
|
929.3
|
865.3
|
P/E ratio
|
16.5
x
|
-12.1
x
|
53.1
x
|
48.3
x
|
20.5
x
|
21.7
x
|
15.2
x
|
16.5
x
|
Yield
|
5.84%
|
1.06%
|
0.18%
|
0.2%
|
0.23%
|
0.22%
|
0.22%
|
0.22%
|
Capitalization / Revenue
|
2.5
x
|
2.42
x
|
2.2
x
|
1.92
x
|
1.62
x
|
1.58
x
|
1.47
x
|
1.47
x
|
EV / Revenue
|
2.94
x
|
2.92
x
|
2.56
x
|
2.24
x
|
1.91
x
|
1.83
x
|
1.6
x
|
1.5
x
|
EV / EBITDA
|
14.5
x
|
18.4
x
|
17
x
|
17.7
x
|
12.6
x
|
11.6
x
|
9.29
x
|
8.81
x
|
EV / FCF
|
29.2
x
|
31
x
|
52.2
x
|
74.4
x
|
68.5
x
|
23.3
x
|
15.3
x
|
12.5
x
|
FCF Yield
|
3.42%
|
3.23%
|
1.91%
|
1.34%
|
1.46%
|
4.3%
|
6.55%
|
8.03%
|
Price to Book
|
9.23
x
|
15.6
x
|
6.47
x
|
5.02
x
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
44,375
|
44,495
|
46,290
|
46,371
|
46,724
|
46,900
|
-
|
-
|
Reference price
2 |
37.67
|
26.51
|
22.31
|
20.27
|
17.66
|
18.13
|
18.13
|
18.13
|
Announcement Date
|
1/29/20
|
1/27/21
|
2/2/22
|
2/1/23
|
1/31/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
668.2
|
487.3
|
470.3
|
489.7
|
509.8
|
537.8
|
579.4
|
576.7
|
EBITDA
1 |
135.8
|
77.44
|
70.81
|
61.98
|
76.96
|
84.71
|
100
|
98.25
|
EBIT
1 |
113.2
|
56.58
|
52.29
|
44.82
|
61.18
|
66.58
|
83.58
|
82.54
|
Operating Margin
|
16.95%
|
11.61%
|
11.12%
|
9.15%
|
12%
|
12.38%
|
14.43%
|
14.31%
|
Earnings before Tax (EBT)
1 |
81.99
|
-91.18
|
36.11
|
-
|
41.21
|
52
|
65
|
70
|
Net income
1 |
102
|
-97.64
|
19.73
|
19.45
|
40.94
|
40.23
|
57.4
|
52
|
Net margin
|
15.26%
|
-20.04%
|
4.19%
|
3.97%
|
8.03%
|
7.48%
|
9.91%
|
9.02%
|
EPS
2 |
2.280
|
-2.200
|
0.4200
|
0.4200
|
0.8600
|
0.8350
|
1.195
|
1.100
|
Free Cash Flow
1 |
67.26
|
45.99
|
23.04
|
14.74
|
14.21
|
42.2
|
60.82
|
69.5
|
FCF margin
|
10.07%
|
9.44%
|
4.9%
|
3.01%
|
2.79%
|
7.85%
|
10.5%
|
12.05%
|
FCF Conversion (EBITDA)
|
49.51%
|
59.38%
|
32.54%
|
23.78%
|
18.46%
|
49.82%
|
60.82%
|
70.74%
|
FCF Conversion (Net income)
|
65.95%
|
-
|
116.79%
|
75.77%
|
34.71%
|
104.9%
|
105.96%
|
133.65%
|
Dividend per Share
2 |
2.200
|
0.2800
|
0.0400
|
0.0400
|
0.0400
|
0.0400
|
0.0400
|
0.0400
|
Announcement Date
|
1/29/20
|
1/27/21
|
2/2/22
|
2/1/23
|
1/31/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
125.1
|
115.3
|
120.9
|
126
|
127.6
|
128.4
|
127.9
|
125.3
|
128.2
|
129.6
|
132.6
|
136.7
|
139.5
|
140.3
|
144.7
|
EBITDA
1 |
18.57
|
11.74
|
13.97
|
17.51
|
18.76
|
18.55
|
19.56
|
19.93
|
18.92
|
18.79
|
20.33
|
22.05
|
23.87
|
22.1
|
25
|
EBIT
1 |
14.17
|
7.184
|
9.607
|
13.34
|
14.69
|
14.51
|
15.62
|
16
|
15.05
|
14.95
|
16.3
|
17.87
|
19.48
|
20
|
19.5
|
Operating Margin
|
11.32%
|
6.23%
|
7.95%
|
10.59%
|
11.51%
|
11.3%
|
12.22%
|
12.76%
|
11.74%
|
11.53%
|
12.29%
|
13.08%
|
13.96%
|
14.25%
|
13.48%
|
Earnings before Tax (EBT)
1 |
11.61
|
-3.035
|
-
|
-
|
-
|
3.052
|
15.67
|
11.52
|
10.96
|
5.148
|
16
|
14
|
17
|
12
|
19
|
Net income
1 |
2.688
|
-1.888
|
7.066
|
7.524
|
6.751
|
2.373
|
22.85
|
9.257
|
6.463
|
3.22
|
11.53
|
11.66
|
13.29
|
10
|
15
|
Net margin
|
2.15%
|
-1.64%
|
5.84%
|
5.97%
|
5.29%
|
1.85%
|
17.87%
|
7.39%
|
5.04%
|
2.48%
|
8.69%
|
8.53%
|
9.53%
|
7.13%
|
10.37%
|
EPS
2 |
0.0600
|
-0.0400
|
0.1500
|
0.1600
|
0.1400
|
-
|
0.4800
|
0.1900
|
0.1400
|
0.0700
|
0.2400
|
0.2500
|
0.2800
|
0.2000
|
0.3200
|
Dividend per Share
2 |
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
Announcement Date
|
2/2/22
|
4/27/22
|
7/27/22
|
10/26/22
|
2/1/23
|
4/26/23
|
7/26/23
|
11/1/23
|
1/31/24
|
4/24/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
294
|
246
|
171
|
157
|
148
|
132
|
79
|
15
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.166
x
|
3.172
x
|
2.414
x
|
2.532
x
|
1.923
x
|
1.558
x
|
0.7899
x
|
0.1527
x
|
Free Cash Flow
1 |
67.3
|
46
|
23
|
14.7
|
14.2
|
42.2
|
60.8
|
69.5
|
ROE (net income / shareholders' equity)
|
46.6%
|
27.3%
|
27.9%
|
15.7%
|
17.9%
|
17.1%
|
19.5%
|
19%
|
ROA (Net income/ Total Assets)
|
11.2%
|
5.23%
|
5.74%
|
4.62%
|
6.48%
|
6.7%
|
7.9%
|
7.5%
|
Assets
1 |
907.4
|
-1,867
|
343.5
|
421.2
|
632.2
|
600.4
|
726.6
|
693.3
|
Book Value Per Share
|
4.080
|
1.700
|
3.450
|
4.040
|
-
|
-
|
-
|
-
|
Cash Flow per Share
2 |
2.010
|
1.300
|
0.7800
|
0.5300
|
0.5200
|
1.240
|
1.680
|
1.770
|
Capex
1 |
22.3
|
11.9
|
13.5
|
10.2
|
10.6
|
14.2
|
14.3
|
14
|
Capex / Sales
|
3.33%
|
2.44%
|
2.88%
|
2.09%
|
2.08%
|
2.64%
|
2.46%
|
2.43%
|
Announcement Date
|
1/29/20
|
1/27/21
|
2/2/22
|
2/1/23
|
1/31/24
|
-
|
-
|
-
|
Last Close Price
18.13
USD Average target price
19.33
USD Spread / Average Target +6.64% Consensus |
1st Jan change
|
Capi.
|
---|
| +2.66% | 850M | | +16.87% | 17.52B | | -16.69% | 2.74B | | -12.60% | 2.67B | | -27.97% | 1.82B | | -5.00% | 1.13B | | -9.36% | 1.04B | | -15.24% | 790M | | -1.66% | 748M | | -25.57% | 663M |
Testing Laboratories
|